Buscar
60 Degrees Pharmaceuticals Inc
SXTPAñadir a la lista de seguimiento
1.710USD
-0.040-2.29%
Cierre 07/02, 13:00（ET）Cotizaciones retrasadas 15 min
1.75MCap. mercado
PérdidaP/E TTM
Más Datos de 60 Degrees Pharmaceuticals Inc Compañía
60 Degrees Pharmaceuticals, Inc. is a specialty pharmaceutical company. The Company specializes in developing and marketing new medicines for the treatment and prevention of infectious diseases. It is focused on using biological science and applied research to develop and commercialize new therapies for the prevention and treatment of infectious diseases. The Company's pipeline under development covers development programs for vector-borne, fungal, and viral disease utilizing three of the Company’s products: new products that contain the ARAKODA regimen of Tafenoquine; new products that contain Tafenoquine, and Celgosivir. Its lead product, ARAKODA is used for malaria prevention in individuals 18 years and older. It is also conducting due diligence activities in relation to potential in-licensing of a product relevant to Lyme disease and an antimalarial combination partner for Tafenoquine for P. vivax malaria.
Información de 60 Degrees Pharmaceuticals Inc
Símbolo de cotizaciónSXTP
Nombre de la empresa60 Degrees Pharmaceuticals Inc
Fecha de salida a bolsaJul 12, 2023
Director ejecutivoDow (Geoffrey S)
Número de empleados3
Tipo de seguridadOrdinary Share
Fin del año fiscalJul 12
Dirección1025 Connecticut Avenue Nw
CiudadWASHINGTON
Bolsa de valoresNASDAQ OMX - NASDAQ BASIC
PaísUnited States of America
Código postal20036
Teléfono12023275422
Sitio Webhttps://60degreespharma.com/
Símbolo de cotizaciónSXTP
Fecha de salida a bolsaJul 12, 2023
Director ejecutivoDow (Geoffrey S)
Ejecutivos de 60 Degrees Pharmaceuticals Inc
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Dr. Geoffrey S. Dow, Ph.D.
Dr. Geoffrey S. Dow, Ph.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
24.13K
+30.46%
Ms. Cheryl Xu
Ms. Cheryl Xu
Director
Director
3.95K
--
Mr. Tyrone Miller
Mr. Tyrone Miller
Chief Financial Officer
Chief Financial Officer
1.32K
--
Ms. Kristen Landon
Ms. Kristen Landon
Chief Commercial Officer
Chief Commercial Officer
1.14K
--
Mr. Charles W. Allen
Mr. Charles W. Allen
Independent Director
Independent Director
59.00
--
Dr. Stephen Toovey
Dr. Stephen Toovey
Independent Director
Independent Director
59.00
--
Mr. Paul Field
Mr. Paul Field
Independent Director
Independent Director
59.00
--
Mr. Patrick Gaynes
Mr. Patrick Gaynes
Investor Relations Officer
Investor Relations Officer
--
--
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Dr. Geoffrey S. Dow, Ph.D.
Dr. Geoffrey S. Dow, Ph.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
24.13K
+30.46%
Ms. Cheryl Xu
Ms. Cheryl Xu
Director
Director
3.95K
--
Mr. Tyrone Miller
Mr. Tyrone Miller
Chief Financial Officer
Chief Financial Officer
1.32K
--
Ms. Kristen Landon
Ms. Kristen Landon
Chief Commercial Officer
Chief Commercial Officer
1.14K
--
Mr. Charles W. Allen
Mr. Charles W. Allen
Independent Director
Independent Director
59.00
--
Dr. Stephen Toovey
Dr. Stephen Toovey
Independent Director
Independent Director
59.00
--
Preguntas frecuentes
¿Quiénes son los cinco principales accionistas de 60 Degrees Pharmaceuticals Inc?
Los cinco principales accionistas de 60 Degrees Pharmaceuticals Inc son: Dr. Geoffrey S. Dow, Ph.D.
¿Cuántas instituciones poseen acciones de 60 Degrees Pharmaceuticals Inc (SXTP)?
A fecha de 2026Q1, 27 instituciones poseen acciones de 60 Degrees Pharmaceuticals Inc, con un valor de mercado combinado de aproximadamente 228.38K, lo que representa el 8.66% del total de acciones. En comparación con el 2025Q4, el accionariado institucional ha aumentado en 141573.00.